Surfactant
- Preterm infants are predisposed to respiratory distress;
- Surfactant only actively secreted from 24 - 26th week
- Alveolar development increases from 32nd week onwards
- The lack of surfactant in preterm infants causes:
- Increased alveolar surface tension
- Higher alveolar instability, leading to collapse
- Impaired gas exchange
- Management involves synthetic surfactant, ventilation (non-invasive, invasive or oscillatory) and prolonged oxygen supplementation
- These infants always need positive pressure ventilation under anaesthesia
Apnoeas
- Preterm neonates are more prone to respiratory apnoeas (pause ≥20s or pause associated with hypoxia/bradycardia)
- The cause is not fully understood; possibly related to neurological maturity
- The clinical response to hypoxia is a period of hyperventilation, followed by apnoea and bradycardia
- A term neonate has a minimal risk of post-operative apnoea after 4 weeks post-natal age and is typically suitable for day surgery
- A preterm neonate should be monitored postoperatively until the 60th post-conceptional week i.e. not suitable for day surgery
- Management of apnoeas
- Avoid GA if possible
- Stimulate the child and open their airway
- Use face-mask oxygen or nasal CPAP
- Close monitoring
- Consider caffeine, either as a prophylaxis or for rescue
- May require intubation
Risk factors increasing likelihood of apnoea |
Hypoglycaemia |
Hypo- or hyper-thermia |
Hypocalcaemia |
Anaemia of prematurity |
Lower gestational age |
Ventilation
- Ventilation in the premature neonate may be complicated by air leaks, necessitating chest drain insertion
- Prolonged intubation and consequent airway oedema increases the risk of developing subglottic stenosis
- Fewer Type 1 (slow twitch) muscle fibres in the diaphragm, so pre-term infants are more prone to respiratory fatigue